Hallie Noecker and Max Voldman wrote an opinion piece for Newsweek maintaining that the Department of Government Efficiency, or DOGE, could have a bigger impact on efficiency if it prioritized using whistleblower information to combat fraud in massive industries like healthcare and defense. The increasingly bold DOGE has been remaking the government at a breakneck […]
Last week, a Phoenix couple pleaded guilty to criminal charges involving healthcare fraud. Unfortunately, this is not remarkable, with approximately 500 annual convictions for healthcare fraud in the U.S. each year over the past five years. What makes this case unique is the staggering size of the fraud. The government alleges that the defendants submitted $1.2 […]
Massachusetts recently enacted a law that might have major impact on investors in the healthcare industry, notable private equity. House Bill 5159 imposes a new rule on those who invest in healthcare companies in the state, requiring disclosure of False Claims Act violations that the companies they invest in may be liable for, or else […]
Whistleblower Partners is proud to announce that the United States has settled our client’s False Claims Act case against international dialysis company DaVita for $34.5 million. The covered conduct concerns allegations of three novel kickback theories involving DaVita’s pharmacy business, its vascular access center business, and medical directorships at dialysis centers. After intervening and settling […]
RELATOR ALLEGED MEDICARE PART C KICKBACKS
We are pleased to announce that Lawdragon has named Chris McLamb to its 2024 “Lawdragon 500 X – The Next Generation” guide, which is designed to identify “the future leaders of the law.” Chris is a Partner in our Washington, DC office. Lawdragon is a leading publisher of “best lawyer” guides recognizing the most effective […]
